1. Investigating the therapeutic effects of nimodipine on vasogenic cerebral edema and blood-brain barrier impairment in an ischemic stroke rat model.
- Author
-
Shadman J, Panahpour H, Alipour MR, Salimi A, Shahabi P, and Azar SS
- Subjects
- Animals, Male, Rats, Disease Models, Animal, Reactive Oxygen Species metabolism, Membrane Potential, Mitochondrial drug effects, Rats, Sprague-Dawley, Intercellular Adhesion Molecule-1 metabolism, Infarction, Middle Cerebral Artery drug therapy, Infarction, Middle Cerebral Artery complications, Mitochondrial Swelling drug effects, Succinate Dehydrogenase metabolism, Nimodipine pharmacology, Brain Edema drug therapy, Brain Edema etiology, Brain Edema metabolism, Blood-Brain Barrier drug effects, Blood-Brain Barrier metabolism, Ischemic Stroke drug therapy, Ischemic Stroke metabolism, Matrix Metalloproteinase 9 metabolism, Calcium Channel Blockers pharmacology
- Abstract
Vasogenic brain edema, a potentially life-threatening consequence following an acute ischemic stroke, is a major clinical problem. This research aims to explore the therapeutic benefits of nimodipine, a calcium channel blocker, in mitigating vasogenic cerebral edema and preserving blood-brain barrier (BBB) function in an ischemic stroke rat model. In this research, animals underwent the induction of ischemic stroke via a 60-min blockage of the middle cerebral artery and treated with a nonhypotensive dose of nimodipine (1 mg/kg/day) for a duration of five days. The wet/dry method was employed to identify cerebral edema, and the Evans blue dye extravasation technique was used to assess the permeability of the BBB. Furthermore, immunofluorescence staining was utilized to assess the protein expression levels of matrix metalloproteinase-9 (MMP-9) and intercellular adhesion molecule-1 (ICAM-1). The study also examined mitochondrial function by evaluating mitochondrial swelling, succinate dehydrogenase (SDH) activity, the collapse of mitochondrial membrane potential (MMP), and the generation of reactive oxygen species (ROS). Post-stroke administration of nimodipine led to a significant decrease in cerebral edema and maintained the integrity of the BBB. The protective effects observed were associated with a reduction in cell apoptosis as well as decreased expression of MMP-9 and ICAM-1. Furthermore, nimodipine was observed to reduce mitochondrial swelling and ROS levels while simultaneously restoring MMP and SDH activity. These results suggest that nimodipine may reduce cerebral edema and BBB breakdown caused by ischemia/reperfusion. This effect is potentially mediated through the reduction of MMP-9 and ICAM-1 levels and the enhancement of mitochondrial function., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Ltd. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF